Get In Touch

Global High-flow Nasal Cannula Market: Snapshot

Some of the prominent participants in the global high flow nasal cannula market are Fisher & Paykel Healthcare Limited, ResMed, Inc., Teijin Pharma Limited, Becton, Dickinson and Company, MEK-ICS CO., LTD., Teleflex Incorporated, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, Hamilton Medical, TNI medical AG, and Great Group Medical Co., Ltd. Of them, Fisher & Paykel Healthcare Limited emerged as the market leader in 2016.

Numerous factors are driving growth in the global high flow nasal cannula market. At the forefront is the ever-increasing number of respiratory disorders. Besides, soaring popularity and uptake of heated humidified high-flow nasal cannulas and increasing investments in research and development programs by companies to come up with better products leveraging more sophisticated technologies is also positively impacting sales. A noticeable trend in the market is the focus of local players on cost-effective products.

A study by Transparency Market Research, predicts the global nasal cannula market to rise at a 11.8% CAGR from 2017 to 2025 to become worth US$9.08 bn by 2025 from US$3.42 bn 2016.

high flow nasal cannula market

Continued Innovations Propel Active Humidifiers Component to Fore

The global high-flow nasal cannula market can be segmented based on different parameters. Depending upon component, for example, the market can be divided into air/oxygen blender, nasal cannulas, active humidifier, single heated tube, and other consumables. Of them, the segment of active humidifier held maximum share in the market in 2016 and it was trailed by the segment of air/oxygen blender. In the near future too, active humidifiers will continue to retain their dominant market share on the back of continued innovations in humidifiers by manufacturers and health care solution providers in order to up their efficacy.

Application-wise, the key segments of the global high-flow nasal cannula market are acute respiratory failure, acute heart failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, sleep apnea, bronchiectasis, etc. The acute respiratory failure segment, of them, held a major share in the market in 2016. It was followed by chronic obstructive pulmonary disease segment. This is because of the rampant acute respiratory failure in newborns, children, and adults.

Ambulatory care centers, long-term care centers, hospitals, etc. are some of the main end-users in the global high-flow nasal cannula market.

Helpful Healthcare and Reimbursement Policies Make North America Market Dominant

From a geographical perspective, currently North America holds a dominant share in the global high-flow nasal cannula market mainly because of the substantial increase in the number of people afflicted with respiratory diseases. Affordability, awareness and helpful healthcare and reimbursement policies are also benefitting the market majorly. By registering an 11.2% CAGR between 2017 and 2025, the market in the region is predicted to grow its dominant share further. The TMR report expects the market to rake in a revenue of US$3.91 bn by 2025.

Europe follows North America in the second position in the global high-flow nasal cannula market. The region is projected to rise at a CAGR of 11.7% from 2017 to 2025 to pull in a revenue of US$2.08 by 2025. In terms of growth rate, on the other hand, Asia Pacific is expected to surpass all other regions by clocking a CAGR of 12.9% in the forecast period. The high-flow cannula market in Asia Pacific is expected to rise on the back of favorable demographics, improved health care policies, and the fast-paced economic growth in the region.

Considerable Technological Progress Made by Market Players to Drive High-flow Nasal Cannula Market

The global high-flow nasal cannula market is expected to be driven by the technological progress made by the prominent market players. In addition to that, clinical trials for the purpose of evaluation of new areas of application are likely to open up new avenues of growth for the global high-flow nasal cannula market in the years to come. Addiction of smoking, increasing level of pollution, and deterioration in the quality of air all over the world is anticipated to work in favor of the market in the years to come.

There has been augmented prevalence of different respiratory disorders across the globe. Acute respiratory failures are foreseen to find extensive use of high-flow oxygen therapy utilizing high-flow nasal cannula, thereby bolstering growth of the market. Covid-19 is a disease caused by SARS-CoV-2 virus affecting upper respiratory tract and leading to its infection. Use of high-flow nasal cannula is expected to provide relief from the complications faced by Covid-19 patients. As such, outbreak of Covid-19 is anticipated to widen scope of growth of the global high-flow nasal cannula market in the forthcoming years.

High Prevalence of Respiratory Diseases, COPD and Asthma, to Propel Market Growth

There has been increasing incidences of chronic obstructive pulmonary disease (COPD) and asthma across the globe. In the last few years, there has been exponential rise in the number of smokers along with the level of pollutants in air, especially in the developing parts of the world. Asthma refers to a medical condition in which airways become narrow and swollen. In this condition, airways also produce mucus and leads to repeated attacks of breathlessness, coughing, and wheezing, which varies in frequency and severity from person to person. In accordance with WHO (World Health Organization), Asthma is one of the major non-communicable diseases worldwide. WHO estimates that there are around 339 million asthma patients in the world. Such wide prevalence of the disease is anticipated to foster development of the global high-flow nasal cannula market in the forthcoming years.

Global High-flow Nasal Cannula Market: Overview

The report on the high-flow nasal cannula market analyzes the current and future scenario of the global market. It has emerged as an innovative respiratory technique, and is expected to replace the conventional low-flow oxygen therapy and other non-invasive ventilation techniques for the treatment of respiratory diseases. The rising incidence of respiratory disorders leading to the increasing number of people requiring oxygen therapy is expected to drive the high-flow nasal cannula market.

The high-flow nasal cannula market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global high-flow nasal cannula market with respect to the segments based on application, component, end user and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter’s five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global high-flow nasal cannula market.

Global High-flow Nasal Cannula Market: Segmentation

Based on component, high-flow nasal cannulas market is segmented into air/oxygen blender, active humidifier, single heated tube, nasal cannulas and other consumables. The market segments have been extensively analyzed based on availability of different high-flow nasal cannula components, product variations available and average price high-flow nasal cannula system. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on application, the high-flow nasal cannula market is segmented as acute respiratory failure, chronic obstructive pulmonary disease (COPD), acute heart failure, carbon monoxide toxicity, sleep apnea, bronchiectasis and other applications. The application market segments have been analyzed based on incidences of the disease and preference for use high-flow nasal cannula among patients. Among applications, the acute respiratory failure segment accounted for a prominent share of the global high-flow nasal cannula market in 2016 whereas the sleep apnea segment is expected to register the maximum CAGR during the forecast period. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on end user, high-flow nasal cannulas market is segmented into hospitals, long-term care centers, ambulatory care centers and other end-users. The market segments have been extensively analyzed based on variations of cannulas provided by the healthcare providers and preference of the patients for the treatment facility. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global high-flow nasal cannula market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Global High-flow Nasal Cannula Market: Competitive Landscape

The report also profiles major players in the global high-flow nasal cannula market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Fisher & Paykel Healthcare Limited, ResMed, Inc., Teijin Pharma Limited, Becton, Dickinson and Company, MEK-ICS CO., LTD., Teleflex Incorporated, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, Hamilton Medical TNI medical AG, Great Group Medical Co., Ltd., and others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The Global High-flow nasal cannulas Market is segmented as given below:

by Component

  • Air/Oxygen Blender
  • Active Humidifier
  • Single Heated Tube
  • Nasal Cannulas
  • Other Consumables

by Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Heart Failure
  • Carbon Monoxide Toxicity
  • Sleep Apnea
  • Bronchiectasis
  • Other Applications

by End User

  • Long-term Care Centers
  • Ambulatory Care Centers
  • Other End-users

by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • U.K.
    • Russia
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global High-flow Nasal Cannula Market 

4. Market Overview
     4.1. Introduction
             4.1.1. Component Definition
             4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
             4.4.1. Drivers
                            4.4.1.1. Rising Incidence of Respiratory Disorders 
                            4.4.1.2. Technology Advances in the High-flow Nasal Cannula Systems
                            4.4.1.3. Growing Applications of the High-flow Nasal Cannula Therapy
             4.4.2. Restraints
                            4.4.2.1. Limitations of the High-flow Nasal Cannula Therapy
             4.4.3. Opportunity
                            4.4.3.1. Large untapped patient population for oxygen therapy
                            4.4.3.2. Increasing focus of health organizations around the world towards home healthcare 
     4.5. Global High-flow Nasal Cannula Market  Analysis and Forecasts, 2015–2025
             4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s Five Force Analysis
     4.7. Value Chain Analysis
     4.8. Market Outlook
     4.9. Brand Share Analysis, by Top Brands, 2016
     4.10. Reimbursement Scenario, By Key Countries (U.S., Germany, Italy, Denmark, Australia & New Zealand, Korea)

5. Global High-flow Nasal Cannula Market Analysis and Forecasts, By Component 
     5.1. Introduction & Definition     
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Component, 2015–2025
             5.4.1. Air/Oxygen Blender
             5.4.2. Active Humidifier
             5.4.3. Single Heated Tube
             5.4.4. Nasal Cannula
             5.4.5. Other Consumables
     5.6. Market Attractiveness By Component 

6. Global High-flow Nasal Cannula Market Analysis and Forecasts, By Application 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Application, 2015–2025
             6.4.1. Acute Respiratory Failure
             6.4.2. chronic obstructive pulmonary disease (COPD)
             6.4.3. Acute Heart Failure 
             6.4.4. Carbon Monoxide Toxicity
             6.4.5. Sleep Apnea
             6.4.6. Bronchiectasis 
             6.4.7. Other Applications
     6.5. Market Attractiveness By Application 

7. Global High-flow Nasal Cannula Market Analysis and Forecasts, By End User 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By End User, 2015–2025
             7.4.1. Hospitals
             7.4.2. Long-term Care Centers
             7.4.3. Ambulatory Care Centers
             7.4.4. Other End-users 
     7.5. Market Attractiveness By End User 

8. Global High-flow Nasal Cannula Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast By Region
             8.3.1. North America 
             8.3.2. Europe  
                          8.3.3. Asia Pacific 
             8.3.4. Latin America 
             8.3.5. Middle East & Africa 
     8.4. Market Attractiveness By Region

9. North America High-flow Nasal Cannula Market Analysis and Forecast
     9.1. Introduction
             9.1.1. Key Findings
             9.1.2. Policies and Regulations
             9.1.3. Key Trends
     9.2. Market Value Forecast By Component, 2015–2025
             9.2.1. Air/Oxygen Blender
             9.2.2. Active Humidifier
             9.2.3. Single Heated Tube
             9.2.4. Nasal Cannula
             9.2.5. Other Consumables
     9.3. Market Value Forecast By Application, 2015–2025
             9.3.1. Acute Respiratory Failure
             9.3.2. chronic obstructive pulmonary disease (COPD)
             9.3.3. Acute Heart Failure 
             9.3.4. Carbon Monoxide Toxicity
             9.3.5. Sleep Apnea
             9.3.6. Bronchiectasis 
             9.3.7. Other Applications
     9.4. Market Value Forecast By End User, 2015–2025
             9.4.1. Hospitals
             9.4.2. Long-term Care Centers
             9.4.3. Ambulatory Care Centers
             9.4.4. Other End-users 
     9.5. Market Value Forecast By Country, 2015–2025
             9.5.1. U.S.
             9.5.2. Canada
     9.6. Market Attractiveness Analysis 
             9.6.1. By Component 
             9.6.2. By Application 
             9.6.3. By End User 
             9.6.4. By Country

10. Europe  High-flow Nasal Cannula Market Analysis and Forecast
     10.1. Introduction
             10.1.1. Key Findings
             10.1.2. Policies and Regulations
             10.1.3. Key Trends
     10.2. Market Value Forecast By Component, 2015–2025
             10.2.1. Air/Oxygen Blender
             10.2.2. Active Humidifier
             10.2.3. Single Heated Tube
             10.2.4. Nasal Cannula
             10.2.5. Other Consumables
     10.3. Market Value Forecast By Application, 2015–2025
             10.3.1. Acute Respiratory Failure
             10.3.2. chronic obstructive pulmonary disease (COPD)
             10.3.3. Acute Heart Failure 
             10.3.4. Carbon Monoxide Toxicity
             10.3.5. Sleep Apnea
             10.3.6. Bronchiectasis 
             10.3.7. Other Applications
     10.4. Market Value Forecast By End User, 2015–2025
             10.4.1. Hospitals
             10.4.2. Long-term Care Centers
             10.4.3. Ambulatory Care Centers
             10.4.4. Other End-users 
     10.5. Market Value Forecast By Country, 2015–2025
             10.5.1. Germany 
             10.5.2. U.K.
             10.5.3. France
             10.5.4. Italy 
             10.5.5. Spain
             10.5.6. Russia 
             10.5.7. Rest of Europe
     10.6. Market Attractiveness Analysis 
             10.6.1. By Component 
             10.6.2. By Application 
             10.6.3. By End User 
             10.6.4. By Country

11. Asia Pacific High-flow Nasal Cannula Market Analysis and Forecast
     11.1. Introduction
             11.1.1. Key Findings
             11.1.2. Policies and Regulations
             11.1.3. Key Trends
     11.2. Market Value Forecast By Component, 2015–2025
             11.2.1. Air/Oxygen Blender
             11.2.2. Active Humidifier
             11.2.3. Single Heated Tube
             11.2.4. Nasal Cannula
             11.2.5. Other Consumables
     11.3. Market Value Forecast By Application, 2015–2025
             11.3.1. Acute Respiratory Failure
             11.3.2. chronic obstructive pulmonary disease (COPD)
             11.3.3. Acute Heart Failure 
             11.3.4. Carbon Monoxide Toxicity
             11.3.5. Sleep Apnea
             11.3.6. Bronchiectasis 
             11.3.7. Other Applications
     11.4. Market Value Forecast By End User, 2015–2025
             11.4.1. Hospitals
             11.4.2. Long-term Care Centers
             11.4.3. Ambulatory Care Centers
             11.4.4. Other End-users 
     11.5. Market Value Forecast By Country, 2015–2025
             11.5.1. China
             11.5.2. India
             11.5.3. Japan
             11.5.4. Australia & New Zealand
             11.5.5. Rest of Asia Pacific
     11.6. Market Attractiveness Analysis 
             11.6.1. By Component 
             11.6.2. By Application 
             11.6.3. By End User 
             11.6.4. By Country

12. Latin America High-flow Nasal Cannula Market Analysis and Forecast
     12.1. Introduction
             12.1.1. Key Findings
             12.1.2. Price Trend Analysis
             12.1.3. Key Trends
     12.2. Market Value Forecast By Component, 2015–2025
             12.2.1. Air/Oxygen Blender
             12.2.2. Active Humidifier
             12.2.3. Single Heated Tube
             12.2.4. Nasal Cannula
             12.2.5. Other Consumables
     12.3. Market Value Forecast By Application, 2015–2025
             12.3.1. Acute Respiratory Failure
             12.3.2. chronic obstructive pulmonary disease (COPD)
             12.3.3. Acute Heart Failure 
             12.3.4. Carbon Monoxide Toxicity
             12.3.5. Sleep Apnea
             12.3.6. Bronchiectasis 
             12.3.7. Other Applications
     12.4. Market Value Forecast By End User, 2015–2025
             12.4.1. Hospitals
             12.4.2. Long-term Care Centers
             12.4.3. Ambulatory Care Centers
             12.4.4. Other End-users 
     12.5. Market Value Forecast By Country, 2015–2025
             12.5.1. Brazil
             12.5.2. Mexico
             12.5.3. Rest of Latin America
     12.6. Market Attractiveness Analysis 
             12.6.1. By Component 
             12.6.2. By Application 
             12.6.3. By End User 
             12.6.4. By Country

13. Middle East & Africa High-flow Nasal Cannula Market Analysis and Forecast
     13.1. Introduction
             13.1.1. Key Findings
             13.1.2. Policies and Regulations
             13.1.3. Key Trends
     13.2. Market Value Forecast By Component, 2015–2025
             13.2.1. Air/Oxygen Blender
             13.2.2. Active Humidifier
             13.2.3. Single Heated Tube
             13.2.4. Nasal Cannula
             13.2.5. Other Consumables
     13.3. Market Value Forecast By Application, 2015–2025
             13.3.1. Acute Respiratory Failure
             13.3.2. chronic obstructive pulmonary disease (COPD)
             13.3.3. Acute Heart Failure 
             13.3.4. Carbon Monoxide Toxicity
             13.3.5. Sleep Apnea
             13.3.6. Bronchiectasis 
             13.3.7. Other Applications
     13.4. Market Value Forecast By End User, 2015–2025
             13.4.1. Hospitals
             13.4.2. Long-term Care Centers
             13.4.3. Ambulatory Care Centers
             13.4.4. Other End-users 
     13.5. Market Value Forecast By Country, 2015–2025
             13.5.1. GCC Countries
             13.5.2. South Africa
             13.5.3. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
             13.6.1. By Component 
             13.6.2. By Application 
             13.6.3. By End User 
             13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis By Company (2016)
     14.3. Company Profiles
             14.3.1. Flexicare Medical Limited
                         14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.1.2. Financial Overview
                         14.3.1.3. Product Portfolio
                         14.3.1.4. SWOT Analysis 
                         14.3.1.5. Strategic Overview
             14.3.2. Teijin Pharma Limited 
                         14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.2.2. Financial Overview
                         14.3.2.3. Product Portfolio
                         14.3.2.4. SWOT Analysis 
                         14.3.2.5. Strategic Overview
             14.3.3. Vapotherm
                         14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.3.2. Financial Overview
                         14.3.3.3. Product Portfolio
                         14.3.3.4. SWOT Analysis 
                         14.3.3.5. Strategic Overview
             14.3.4. Salter Labs
                         14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.4.2. Financial Overview
                         14.3.4.3. Product Portfolio
                         14.3.4.4. SWOT Analysis 
                         14.3.4.5. Strategic Overview
             14.3.5. Teleflex Incorporated
                         14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.5.2. Financial Overview
                         14.3.5.3. Product Portfolio
                         14.3.5.4. SWOT Analysis 
                         14.3.5.5. Strategic Overview
             14.3.6. Fisher & Paykel Healthcare Limited
                         14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.6.2. Financial Overview
                         14.3.6.3. Product Portfolio
                         14.3.6.4. SWOT Analysis 
                         14.3.6.5. Strategic Overview
             14.3.7. ResMed, Inc.
                         14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.7.2. Financial Overview
                         14.3.7.3. Product Portfolio
                         14.3.7.4. SWOT Analysis 
                         14.3.7.5. Strategic Overview
             14.3.8. Smiths Medical 
                         14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.8.2. Financial Overview
                         14.3.8.3. Product Portfolio
                         14.3.8.4. SWOT Analysis 
                         14.3.8.5. Strategic Overview
             14.3.9. Hamilton Medical 
                         14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.9.2. Financial Overview
                         14.3.9.3. Product Portfolio
                         14.3.9.4. SWOT Analysis 
                         14.3.9.5. Strategic Overview
             14.3.10. TNI Medical AG
                         14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.10.2. Financial Overview
                         14.3.10.3. Product Portfolio
                         14.3.10.4. SWOT Analysis 
                         14.3.10.5. Strategic Overview
             14.3.11. Great Group Medical Co., Ltd.
                         14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.11.2. Financial Overview
                         14.3.11.3. Product Portfolio
                         14.3.11.4. SWOT Analysis 
                         14.3.11.5. Strategic Overview
             14.3.12. MEK-ICS CO., Ltd.
                         14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.12.2. Financial Overview
                         14.3.12.3. Product Portfolio
                         14.3.12.4. SWOT Analysis 
                         14.3.12.5. Strategic Overview
             14.3.13. Becton, Dickinson and Company 
                         14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.13.2. Financial Overview
                         14.3.13.3. Product Portfolio
                         14.3.13.4. SWOT Analysis 
                         14.3.13.5. Strategic Overview
             14.3.14. Others

15. Key Take Aways

List of Tables

Table 01: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 02: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 07: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 08: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 11: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 15: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 16: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 19: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 23: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025

List of Figures

Figure 01: Global High-flow Nasal Cannula Market Snapshot
Figure 02: Global High-flow Nasal Cannula, Market Size (US$ Mn) Forecast, 2015–2025
Figure 03: Global High-flow Nasal Cannula Market Value Share, by Application (2016)
Figure 04: Global High-flow Nasal Cannula Market Value Share, by Component  (2016)
Figure 05: Global High-flow Nasal Cannula Market Value Share, by End User (2016)
Figure 06: Global High-flow Nasal Cannula Market Value Share, by Region (2016)
Figure 07: Global High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 08: Global High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 09: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Air/Oxygen Blender, 2015–2025
Figure 10: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Active Humidifier, 2015–2025
Figure 11: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Single Heated Tube, 2015–2025
Figure 12: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nasal Cannula, 2015–2025
Figure 13: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Consumables, 2015–2025
Figure 14: Global High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 15: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Acute Respiratory Failure Application, 2015–2025
Figure 16: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Chronic Obstructive Pulmonary Disease Application, 2015–2025
Figure 17: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Acute Heart Failure Application, 2015–2025
Figure 18: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Carbon Monoxide Toxicity Application, 2015–2025
Figure 19: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Sleep Apnea Application, 2015–2025
Figure 20: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Bronchiectasis Application, 2015–2025
Figure 21: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Applications, 2015–2025
Figure 22: Global High-flow Nasal Cannula Market Attractiveness, by Application, 2017-2025
Figure 23: Global High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 24: Global High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 25: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospitals, 2015–2025
Figure 26: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Long-term Care Centers, 2015–2025
Figure 27: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ambulatory Care Centers, 2015–2025
Figure 28: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other End Users, 2015–2025
Figure 29: Global High-flow Nasal Cannula Market Value Share, by Region, 2017 and 2025 
Figure 30: Global High-flow Nasal Cannula Market Attractiveness, by Region, 2017–2025
Figure 31: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 32: North America High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025
Figure 33: North America High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 34: North America High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 35: North America High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 36: North America High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 37: North America High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 38: North America High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 39: North America High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 40: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 41: Europe High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025 
Figure 42: Europe High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 43: Europe High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 44: Europe High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 45: Europe High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 46: Europe High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 47: Europe High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 48: Europe High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 49: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 50: Asia Pacific High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025 
Figure 51: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 52: Asia Pacific High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 53: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 54: Asia Pacific High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 55: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 56: Asia Pacific High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 57: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 58: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 59: Latin America High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025 
Figure 60: Latin America High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 61: Latin America High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 62: Latin America High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 63: Latin America High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 64: Latin America High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 65: Latin America High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 66: Latin America High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 67: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 68: Middle East & Africa High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025 
Figure 69: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 70: Middle East & Africa High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 71: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 72: Middle East & Africa High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 73: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 74: Middle East & Africa High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 75: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 76: Global High-flow Nasal Cannula Market Share, by Company, 2016

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

High Flow Nasal Cannula Market